| Ashley Klinger, | |
|
8012 Stewart Mountain Dr, Eagle River, AK 99577-9013 | |
| (907) 694-3336 | |
| Not Available |
| Full Name | Ashley Klinger |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 8012 Stewart Mountain Dr, Eagle River, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023747540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Klinger, 2600 Cordova St Ste 101, Anchorage, AK 99503-2745 Ph: (907) 279-9640 | Ashley Klinger, 8012 Stewart Mountain Dr, Eagle River, AK 99577-9013 Ph: (907) 694-3336 |
News Archive
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds light on how interferon-gamma (IFN-y), an immune response-stimulating signaling molecule that helps activate immune cells, guides the treatment response in people with advanced melanoma who are treated with one of the leading immunotherapies -; immune checkpoint blockade.
High intensity physical activity in early life might help maximise peak hip strength and prevent osteoporosis in later life, according to a study published in JAMA Network Open from researchers at the University of Bristol.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL Vascular Closure Device in the US. EXOSEAL incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure.
Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.
Aduro BioTech, Inc. announces completion of enrollment in the Phase 2 clinical trial of the sequential administration of two cancer vaccines, Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine, in patients with metastatic pancreatic cancer.
› Verified 7 days ago
Austin Didrickson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 8012 Stewart Mountain Dr, Eagle River, AK 99577 Phone: 907-694-3336 | |
Mr. Sammie O'neal Iii, MA, CDC1 Counselor Medicare: Not Enrolled in Medicare Practice Location: 12518 Crested Butte Dr, Eagle River, AK 99577 Phone: 907-406-3033 | |
Gina Thara Wall, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 17601 James Way, Eagle River, AK 99577 Phone: 907-854-2344 | |
Robin Forman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 8012 Stewart Mountain Dr, Eagle River, AK 99577 Phone: 907-694-3336 | |
Kristin Stadsklev, CDC1 Counselor Medicare: Not Enrolled in Medicare Practice Location: 8012 Stewart Mountain Dr, Eagle River, AK 99577 Phone: 907-694-3336 | |
Adam Abdallah, Counselor Medicare: Not Enrolled in Medicare Practice Location: 8012 Stewart Mountain Dr, Eagle River, AK 99577 Phone: 907-694-8840 |